Wellcome Trust

Trending Articles

  1. Wacker Biotech to manufacture protein ingredients for MinervaX's late-stage GBS vaccine The vaccine is currently being prepared for Phase III trials, and aims to protect mothers and their babies from group B streptococcus infections
  2. Novartis' Kisqali plus ET bags FDA approval for HR+/HER2- breast cancer The decision comes off the back of the Phase III NATALEE clinical trial, which diminished the risk of disease recurrence by 25.1%
  3. AstraZeneca opens a 'people hub' at its Macclesfield site The energy-efficient building will offer AZ employees a collaborative space
  4. Ensuring cGMP compliance in cell and gene therapy manufacturing 3P discusses how companies can scale up their CGT manufacturing protocols while remaining compliant with stringent global regulations
  5. Piramal Pharma's sustainability goals get SBTi-validated The company wants to reduce its scope 1 and 2 GHG emissions by 42% by 2030, and is also working on developing a carbon reduction plan

Upcoming event

Boston Biotech Week

23-26 September, 2024 | Convention and exhibition | Boston, US See all

Related Content

Research & Development

Oxford clinical trial for COVID-19 treatments expands internationally

The international trial will initially focus on the treatments aspirin and colchicine, since these are readily available and affordable
Research & Development

Study demonstrates way to target hard-to-treat cancer mutation

The study was funded by Cancer Research UK and Wellcome
Research & Development

Collaborators use CRISPR to catch cancer-causing gene fusions

A team from the Wellcome Sanger Institute and collaborators have identified a new gene fusion that presents a novel drug target for multiple cancers, including brain and ovarian
Finance

Karuna completes $42 million financing round

Participants include ARCH Venture Partners, Wellcome Trust, PureTech Health, Steven Paul MD, and other undisclosed investors
Hi Tech Manufacturing

£10m research competition to tackle antimicrobial resistance

Move aims to encourage the development of innovative scientific approaches to addressing antimicrobial resistance
Regulatory

Karuna receives $8m Wellcome Trust award

The funding will be used to advance the company's lead product candidate, KarXT, through a Phase II study in people with schizophrenia
Research & Development

Polyphor and Wellcome Trust to develop novel antibiotics against multi-drug resistant Gram-negative pathogens

Final milestone reached ahead of schedule triggering payment of a CHF 0.97 million convertible loan amount
Subscribe now